Chelator boosted tumor-retention and pharmacokinetic properties: development of (64)Cu labeled radiopharmaceuticals targeting neurotensin receptor
螯合剂增强肿瘤滞留和药代动力学特性:靶向神经降压素受体的 (64)Cu 标记放射性药物的开发
期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-024-06754-2
Zhang, Tao; Ma, Xinrui; Xu, Muyun; Cai, Jinghua; Cai, Jianhua; Cao, Yanguang; Zhang, Zhihao; Ji, Xin; He, Jian; Cabrera, German Oscar Fonseca; Wu, Xuedan; Zhao, Weiling; Wu, Zhanhong; Xie, Jin; Li, Zibo